How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?
Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
Vestis (NYSE:VSTS) Exceeds Q3 CY2025 Expectations But Stock Drops
Uniform rental provider Vestis Corporation (NYSE:VSTS) announced better-than-expected revenue in Q3 CY2025, with sales up 4.1% year on…